Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neurocrine Biosciences, Inc. - Common Stock (NQ:NBIX)

154.76 +1.01 (+0.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 944,420
Open 153.86
Bid (Size) 142.00 (100)
Ask (Size) 160.00 (100)
Prev. Close 153.75
Today's Range 152.86 - 155.64
52wk Range 84.23 - 157.67
Shares Outstanding 99,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Neurocrine Biosciences Inc (NASDAQ:NBIX) Fits the Affordable Growth Profile
Neurocrine Biosciences (NBIX) offers strong growth, solid profitability, and a reasonable valuation, fitting an affordable growth investing strategy. 
Via Chartmill
Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents a Compelling Value Investment Case
Neurocrine Biosciences (NBIX) is a strong value stock with a debt-free balance sheet, high profitability, and solid growth, trading at a discount to its industry peers. 
Via Chartmill

Performance

YTD
+12.3%
+12.3%
1 Month
+11.0%
+11.0%
3 Month
+20.5%
+20.5%
6 Month
+27.3%
+27.3%
1 Year
+27.3%
+27.3%

More News

Read More
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Q3 2025 Earnings Top Estimates, Driving Stock Momentum
Via Chartmill
Neurocrine Bio Surges After Crushing Third-Quarter Expectations
Via Investor's Business Daily
Examining the Future: Neurocrine Biosciences's Earnings Outlook
Via Benzinga
Earnings Scheduled For July 30, 2025
Via Benzinga
S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday?
Via Benzinga
Topics Economy Stocks
Earnings Scheduled For October 28, 2025
Via Benzinga
What 13 Analyst Ratings Have To Say About Neurocrine Biosciences
Via Benzinga
Demystifying Neurocrine Biosciences: Insights From 12 Analyst Reviews
Via Benzinga
Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents an Affordable Growth Opportunity
Via Chartmill
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Presents a Compelling Growth and Breakout Opportunity
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Neurocrine Biosciences Inc (NASDAQ:NBIX): An Affordable Growth Candidate in Biotechnology
Via Chartmill
Where Neurocrine Biosciences Stands With Analysts
Via Benzinga
Neurocrine Biosciences Inc (NASDAQ:NBIX) Screened as a Strong Growth Stock with Bullish Technical Setup
Via Chartmill
Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views
Via Benzinga
Neurocrine Biosciences Inc (NASDAQ:NBIX): A Prime GARP Candidate with Strong Growth and Reasonable Valuation
Via Chartmill
Neurocrine (NBIX) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Neurocrine (NBIX) Q2 Revenue Jumps 17%
Via The Motley Fool
The Analyst Verdict: Neurocrine Biosciences In The Eyes Of 17 Experts
Via Benzinga
Neurocrine Biosciences Inc (NASDAQ:NBIX): A Strong Affordable Growth Pick with Solid Fundamentals
Via Chartmill
Neurocrine Biosciences Inc (NASDAQ:NBIX) Beats Q2 2025 Earnings Estimates but Stock Drops 8.6% on Investor Concerns
Via Chartmill
Neurocrine Biosciences Inc (NASDAQ:NBIX) Emerges as a Strong Growth Stock with Breakout Potential
Via Chartmill
Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
Via Investor's Business Daily
Topics Intellectual Property

Frequently Asked Questions

Is Neurocrine Biosciences, Inc. - Common Stock publicly traded?
Yes, Neurocrine Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Neurocrine Biosciences, Inc. - Common Stock trade on?
Neurocrine Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neurocrine Biosciences, Inc. - Common Stock?
The ticker symbol for Neurocrine Biosciences, Inc. - Common Stock is NBIX on the Nasdaq Stock Market
What is the current price of Neurocrine Biosciences, Inc. - Common Stock?
The current price of Neurocrine Biosciences, Inc. - Common Stock is 154.76
When was Neurocrine Biosciences, Inc. - Common Stock last traded?
The last trade of Neurocrine Biosciences, Inc. - Common Stock was at 11/06/25 04:00 PM ET
What is the market capitalization of Neurocrine Biosciences, Inc. - Common Stock?
The market capitalization of Neurocrine Biosciences, Inc. - Common Stock is 15.43B
How many shares of Neurocrine Biosciences, Inc. - Common Stock are outstanding?
Neurocrine Biosciences, Inc. - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.